Ianalumab is a fully human monoclonal antibody designed to deplete B cells via antibody-dependent cellular toxicity and inhibit BAFF-R-mediated signals of B cell function and survival.

The prevalence of drinking alcohol in the US has declined in recent years while belief that drinking is unhealthy has increased.